Insider · CIK 0001598542

Carroll Jill

Reports to the SEC for 4 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001598542

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-01	AVLNAvalyn Pharma Inc.C Conversion	Director	CConversion	+1.42M sh	—	—	1,419,298
2026-05-01	AVLNAvalyn Pharma Inc.C Conversion	Director	CConversion	+489K sh	—	—	1,908,784
2026-05-01	AVLNAvalyn Pharma Inc. · Series D Convertible Preferred StockC Conversion	Director	CConversion	−9.42M sh	—	—	0
2026-05-01	AVLNAvalyn Pharma Inc. · Series C-1 Convertible Preferred StockC Conversion	Director	CConversion	−27.3M sh	—	—	0
2026-05-01	AVLNAvalyn Pharma Inc.P Purchase	Director	PPurchase	+278K sh	$18.00	+$5M	2,186,562
2026-04-28	Arcellx, Inc.U Disposition from Tender	Director	UDisposition from Tender	−1.48M sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11.5K sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,011 sh	—	—	0
2026-04-28	Arcellx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,174 sh	—	—	0
2025-05-29	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,174 sh	—	—	9,174
2024-05-28	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,011 sh	—	—	8,011
2024-03-21	Arcellx, Inc.S Sale	Director	SSale	−504K sh	$70.55	−$35.6M	1,479,148
2023-12-14	Arcellx, Inc.S Sale	Director	SSale	−504K sh	$49.13	−$24.8M	1,983,411
2023-06-14	Arcellx, Inc.Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,459
2023-06-01	Arcellx, Inc.S Sale	Director	SSale	−25.6K sh	$44.35	−$1.13M	2,487,674
2023-05-31	Arcellx, Inc.S Sale	Director	SSale	−315K sh	$41.50	−$13.1M	2,513,230
2023-05-11	Arcellx, Inc.S Sale	Director	SSale	−632K sh	$45.00	−$28.4M	2,834,879
2023-05-11	Arcellx, Inc.S Sale	Director	SSale	−6,485 sh	$46.15	−$299K	2,828,394
2022-02-08	Arcellx, Inc.Series C Preferred StockC Conversion	Director	CConversion	−433K sh	—	—	0
2022-02-08	Arcellx, Inc.C Conversion	Director	CConversion	+3.4M sh	—	—	3,400,144
2022-02-08	Arcellx, Inc.P Purchase	Director	PPurchase	+66.7K sh	$15.00	+$1M	3,466,811
2022-02-08	Arcellx, Inc.C Conversion	Director	CConversion	+433K sh	—	—	433,196
2022-02-08	Arcellx, Inc.P Purchase	Director	PPurchase	+1.6M sh	$15.00	+$24M	2,033,196
2022-02-08	Arcellx, Inc.Series A Preferred StockC Conversion	Director	CConversion	−1.55M sh	—	—	0
2022-02-08	Arcellx, Inc.Series B-1 Preferred StockC Conversion	Director	CConversion	−667K sh	—	—	0
2022-02-08	Arcellx, Inc.Series B-2 Preferred StockC Conversion	Director	CConversion	−533K sh	—	—	0
2022-02-08	Arcellx, Inc.Series C Preferred StockC Conversion	Director	CConversion	−650K sh	—	—	0
2021-04-01	Pandion Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, 10% Owner	DDisposition to Issuer	−14K sh	—	—	0
2021-04-01	Pandion Therapeutics, Inc.U Disposition from Tender	Director, 10% Owner	UDisposition from Tender	−5.67M sh	$60.00	−$340M	0
2020-07-21	Pandion Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+361K sh	$18.00	+$6.5M	2,248,304
2020-07-21	Pandion Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+348K sh	—	—	1,887,193
2020-07-21	Pandion Therapeutics, Inc.C Conversion	Director, 10% Owner	CConversion	+1.54M sh	—	—	1,538,724
2020-07-21	Pandion Therapeutics, Inc.Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.78M sh	—	—	0
2020-07-21	Pandion Therapeutics, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−7.85M sh	—	—	0
2020-07-17	Pandion Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+14K sh	—	—	13,997

Recent filings

Accepted (ET)
May 14
Carroll Jill0001193125-26-201894
SEC(opens sec.gov)
Apr 284
Carroll Jill0001193125-26-188029
SEC(opens sec.gov)
May 304
Carroll Jill0000950170-25-079730
SEC(opens sec.gov)
Jun 64
Carroll Jill0000950170-24-069955
SEC(opens sec.gov)
Mar 254
Carroll Jill0000950170-24-036013
SEC(opens sec.gov)
Dec 184
Carroll Jill0001209191-23-058974
SEC(opens sec.gov)
Jun 164
Carroll Jill0001209191-23-037969
SEC(opens sec.gov)
Jun 24
Carroll Jill0001209191-23-033867
SEC(opens sec.gov)
May 154
Carroll Jill0001209191-23-029613
SEC(opens sec.gov)
Feb 94
Carroll Jill0001209191-22-008157
SEC(opens sec.gov)

Companies

Address

929 MAIN STREET SUITE 200

REDWOOD CITY, CA, 94063